Orofacial Functions and Masticatory Function in Children With Different Types of Deterioration in Oral Health
Launched by UNIVERSITY HOSPITAL, CLERMONT-FERRAND · Apr 6, 2023
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying how children's ability to chew food changes as they receive dental treatment for different oral health issues. The researchers want to understand how factors like the type of dental problem, eating habits, and the child's growth (height and weight) relate to their chewing skills during the treatment process. Children will undergo regular check-ups and tests every six months over a five-year period to monitor their oral health and chewing abilities, including how well they can chew various foods.
To participate in this study, children aged 3 to 17 years who are receiving care at specific dental units in France may be eligible. They need permission from their legal guardians, and the study includes those with various dental needs, from multiple cavities to healthy oral status. Participants can expect routine dental care during the study, along with assessments that will help improve understanding of how dental health influences chewing and overall quality of life for children and their families.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- * All children, from 3 to 17 years old (inclusion limits), attending the special dental care unit of the CHU Estaing in Clermont Ferrand or the CH Guy Thomas in Riom are included in the study:
- • Children and adolescents who have given their consent (6-17 years) and whose legal guardians have given their consent.
- • Children (3-6 years old) with consent from the legal guardian.
- • The subject is affiliated with a Social Security system.
- This may include:
- • 1. children with multiple caries, requiring full rehabilitation under sedation or general anesthesia +/- prosthetic rehabilitation,
- • 2. children with orofacial dysmorphologies/malocclusions, associated or not with a general syndrome, requiring orthodontic and/or prosthetic treatment
- • 3. children with dental abnormalities, associated or not with a general syndrome, requiring conservative, orthodontic and/or prosthetic treatment,
- • 4. children with a healthy oral status in the course of their bi-annual oral health chek-up.
- Exclusion criteria:
- • Children with an ASA III or IV category according to the American Society of Anesthesiologists
- • Children who do not have a solid diet due to severe neuromotor disorders.
- • Children for whom a geographical or organizational barrier prevents follow-up in the service, children in social placement
- • Children over 18 years of age
- • Children (6-17 years) who do not volunteer to participate
- • Children (6-17 years old) who are unable to give consent to participate in the research.
- • Children for whom one of the legal guardians refuses to participate in the study
- • Children whose legal guardians are not capable of giving informed consent.
- • Children who are not affiliated to a Social Security system.
- • Pregnant or nursing teenagers
About University Hospital, Clermont Ferrand
The University Hospital of Clermont-Ferrand is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical trials. Renowned for its multidisciplinary approach, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes collaboration among healthcare professionals, researchers, and academic partners. With a strong commitment to improving patient outcomes, the institution actively engages in a wide array of clinical studies, ranging from early-phase trials to large-scale interventions, aimed at addressing critical health challenges and enhancing treatment modalities. Its state-of-the-art facilities and expertise make it a pivotal contributor to clinical research in the region and beyond.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Clermont Ferrand, , France
Patients applied
Trial Officials
Valérie Collado
Principal Investigator
University Hospital, Clermont-Ferrand
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported